Case Report: Comorbid Hyper-IgD Syndrome and Hidradenitis Suppurativa - A New Syndromic Form of HS? A Report of Two Cases.
autoinflammation
autoinflammatory keratinization disease
hidradenitis suppurativa
hyper-IgD syndrome
mevalonate kinase deficiency
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2022
2022
Historique:
received:
25
02
2022
accepted:
26
04
2022
entrez:
20
6
2022
pubmed:
21
6
2022
medline:
22
6
2022
Statut:
epublish
Résumé
Hidradenitis Suppurativa (HS) is a chronic suppurative disease of the pilosebaceous unit. The current model of HS pathophysiology describes the condition as the product of hyperkeratinisation and inflammation at the hair follicular unit. Environmental factors (such as smoking and obesity), gender, genetic predisposition, and skin dysbiosis are considered the main pathogenic drivers of the disease. Autoinflammatory syndromes associated with HS are rare but may help to highlight the potential roles of autoinflammation and dysregulated innate immune system in HS. Therefore, it is of major relevance to increase the awareness about these diseases in order to improve the understanding of the disease and to optimize the management of the patients. Herein, we report for the first time, to our knowledge, two clinical cases of Hyper-IgD syndrome-associated HS. Hyper-IgD is an autoinflammatory syndrome caused by a mevalonate kinase deficiency (MKD), a key kinase in the sterol and isoprenoid production pathway. We describe the potentially shared pathophysiological mechanisms underpinning comorbid MKD-HS and propose therapeutic options for the management of these patients.
Identifiants
pubmed: 35720358
doi: 10.3389/fimmu.2022.883811
pmc: PMC9204359
doi:
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
883811Informations de copyright
Copyright © 2022 Guillem, Mintoff, Kabbani, Cogan, Vlaeminck-Guillem, Duquesne and Benhadou.
Déclaration de conflit d'intérêts
PG received honoraria from AbbVie and Novartis as a consultant and provided lectures for AbbVie, Brothier, Cicaplus, Coloplast, Inresa and Novartis. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Br J Dermatol. 2019 Sep;181(3):483-491
pubmed: 30724351
Front Med (Lausanne). 2020 Mar 04;7:68
pubmed: 32195261
F1000Res. 2018 Dec 13;7:1930
pubmed: 30828428
Clin Dermatol. 2021 Mar-Apr;39(2):240-247
pubmed: 34272017
Dermatology. 2022 Jan 14;:1-10
pubmed: 35034021
Dermatology. 2021;237(5):673-697
pubmed: 32942279
Front Immunol. 2020 May 20;11:847
pubmed: 32508815
PLoS One. 2020 Aug 21;15(8):e0237999
pubmed: 32822427
Br J Dermatol. 2019 Oct;181(4):852-854
pubmed: 30968946
Br J Dermatol. 2017 Nov;177(5):1401-1409
pubmed: 28636793
JAMA Dermatol. 2021 Aug 01;157(8):924-931
pubmed: 34037678
JAMA Dermatol. 2022 Mar 01;158(3):300-313
pubmed: 35044423
Exp Dermatol. 2020 Dec;29(12):1154-1170
pubmed: 33058306
Science. 2010 Nov 19;330(6007):1065
pubmed: 20929727
JAAD Int. 2020 Jun 27;1(1):62-72
pubmed: 34409324